De novo germline mutations of the p53 gene in young children with sarcomas

Oncology Reports

Volumn 4, Issue 4, 1997, Pages 679-683

  Ayan, Inci ^a   Luca, James W ^b   Jaffe, Norman ^b   Strong, Louise C ^b   Hansen, Marc F ^b,c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Childhood sarcoma; De novo mutation; Osteosarcoma; p53; Rhabdomyosarcoma

Indexed keywords

ADRENAL CORTEX CARCINOMA; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CHILD; DOMINANT GENE; FAMILIAL CANCER; GENE DUPLICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OSTEOSARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

EID: 0030753010     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.4.679     Document Type: Article

References (48)

1. Levine AJ: The p53 tumor-suppressor gene. N Engl J Med 326: 1350-1352, 1992.
2. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
3. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
4. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC: Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24: 141-146, 1996.
5. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R and Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22: 3551-3555, 1994.
6. Malkin D, Li FP, Strong LC, Fraumeni JFJ, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend SF: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238, 1990.
7. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Borresen AL, Li FP, Garber J, et al: Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326: 1309-1315, 1992.
8. Srivastava S, Zou ZQ, Pirollo K, Blattner W and Chang EH: Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348: 747-749, 1990.
9. Srivastava S, Wang S, Tong YA, Pirollo K and Chang EH: Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 8: 2449-2456, 1993.
10. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen AL, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D and Gebhardt MC: Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12: 925-930, 1994.
11. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, et al: Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326: 1301-1308, 1992.
12. Frebourg T and Friend SH: Cancer risks from germline p53 mutations. J Clin Invest 90: 1637-1641, 1992.
13. 13: Santibanez-Koref MF, Birch JM, Hartley AL, Jones PH, Craft AW, Eden T, Crowther D, Kelsey AM and Harris M: p53 germline mutations in Li-Fraumeni syndrome. Lancet 338: 1490-1491, 1991.
14. Harris CC and Hollstein M: Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329: 1318-1327, 1993.
15. Hinds PW and Weinberg RA: Tumor suppressor genes. Curr Opin Gene Develop 4: 135-141, 1994.
16. Li FP and Fraumeni JF: Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 71: 747-752, 1969.
17. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW: A cancer family syndrome in twenty-four kindreds. Cancer Res 48: 5358-5362, 1988.
18. Malkin D and Friend SH: The role of tumour suppressor genes in familial cancer. Semin Cancer Biol 3: 121-130, 1992.
19. Birch JM: Familial cancer syndromes and clusters. Br Med Bull 50: 624-639, 1994.
20. Birch JM: Li-Fraumeni syndrome. Eur J Cancer 30A: 1935-1941, 1994.
21. Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR, Blake PR, Tait DM, Lane DP, Easton DF, et al: Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 8: 1269-1276, 1993.
22. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, et al: A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8: 1203-1210, 1993.
23. Gutierrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS and Magrath IT: A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Molec Genet 3: 2247-2248, 1994.
24. Iavarone A, Matthay KK, Steinkirchner TM and Israel MA: Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma. Proc Natl Acad Sci USA 89: 4207-4209, 1992.
25. Luca JW, Strong LC and Hansen MF: A germline missense mutation in exon 10 of the human p53 gene. Hum Mut (In press).
26. Diller L, Sexsmith E, Gottlieb A, Li FP and Malkin D: Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 95: 1606-1611, 1995.
27. Wagner J, Portwine C, Rabin K, Leclerc JM, Narod SA and Malkin D: High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86: 1707-1710, 1994.
28. Grayson GH, Moore S, Schneider BG, Saldivar V and Hensel CH: Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma. Am J Pediatric Hematol-Oncol 16: 341-347, 1994.
29. Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA and Saya H: Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst 86: 344-349, 1994.
30. Chen P, Iavarone A, Fick J, Edwards M, Prados M and Israel MA: Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genet Cytogenet 82: 106-115, 1995.
31. Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B and Davidson N: Inherited p53 gene mutations in breast cancer. Cancer Res 52: 2984-2986, 1992.
32. Birch JM: Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges. Br J Cancer 66: 424-426, 1992.
33. Eeles RA: Predictive testing for germline mutations in the p53 gene: are all the questions answered? Eur J Cancer 29A: 1361-1365, 1993.
34. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC and White RL: Expression of recessive alleles by chromosomal mechanisms in retino-blastoma. Nature 305: 779-784, 1983.
35. Hansen MF and Cavenee WK: Genetics of cancer predisposition. Cancer Res 47: 5518-5527, 1987.
36. Li FP, Correa P and Fraumeni JF: Testing for germ line mutations in cancer families. Cancer Epidem Biomarker Prev 1: 91-94, 1991.
37. Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988.
38. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T and Hayashi K: Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313-1318, 1991.
39. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1989.
40. Orita M, Suzuki Y, Sekiya T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-879, 1989.
41. Brugieres L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaiti-Pellie C, Lemerle J, et al: Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res 53: 452-455, 1993.
42. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibanez-Koref MF: Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304, 1994.
43. MacGeoch C, Turner G, Bobrow LG, Barnes DM, Bishop DT and Spurr NK: Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. J Med Genet 32: 186-190, 1995.
44. Knudson AG: Mutation and cancer: a statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.
45. Knudson AG, Hethcote HW and Brown BW: Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 72: 5116-5120, 1975.
46. Knudson AG and Strong LC: Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 48: 313-333, 1972.
47. Knudson AG: Genetics and the etiology of childhood cancer. Pediatr Res 10: 513-517, 1976.
48. Frebourg T, Malkin D and Friend S: Cancer risks from germ line tumor suppressor gene mutations. Int Symp Princess Takamatsu Cancer Res Fund 22: 61-70, 1991.